Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/25 19:04 | 11/17/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC,Secre | 6 | S.d | -239 | 9.85 | 0 | -24 | 63 | D | |||||||||||||||
11/18/25 19:02 | 11/17/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO | 6 | S.d | -214 | 9.72 | 0 | -22 | 295 | D | |||||||||||||||
11/18/25 19:00 | 11/17/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 3 | S.d | -83 | 7.29 | 0 | -11 | 51 | D | |||||||||||||||
11/18/25 18:59 | 11/17/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 6 | S.d | -771 | 9.73 | 0 | -79 | 1,786 | D | |||||||||||||||
12/12/24 16:06 | 12/10/24 | DAWN | Health | Drug | Pharmaceutical Preparations | Blackman Samuel C. | CA | O | HEAD OF | 8 | S.dm | -1,851 | 14.88 | 0 | -124 | 2,128 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |